Close X
Tuesday, November 26, 2024
ADVT 
International

Omicron not mild, hospitalising and killing people: WHO chief

Darpan News Desk IANS, 06 Jan, 2022 02:05 PM
  • Omicron not mild, hospitalising and killing people: WHO chief

Geneva, Jan 6 (IANS) While Omicron does appear to be less severe compared to Delta, especially in those vaccinated, it does not mean it should be categorised as 'mild' as just like previous variants, Omicron is hospitalising people and it is killing people, WHO Director-General Dr Tedros Adhanom Ghebreyesus said on Thursday.

In fact, the tsunami of cases is so huge and quick, that it is overwhelming health systems around the world, he stressed.

"Hospitals are becoming overcrowded and understaffed, which further results in preventable deaths from not only Covid-19 but other diseases and injuries where patients cannot receive timely care," saidGhebreyesus.

According to him, first-generation vaccines may not stop all infections and transmission but they remain highly effective in reducing hospitalisation and death from this virus.

"So as well as vaccination, public health social measures, including the wearing of well-fitting masks, distancing, avoiding crowds and improving and investing in ventilation are important for limiting transmission," he stressed.

At the current pace of vaccine rollout, 109 countries would miss out on fully vaccinating 70 per cent of their populations by the start of July 2022.

Last week, the highest number of Covid-19 cases were reported so far in the pandemic.

"And we know, for certain, that this is an underestimate of cases because reported numbers do not reflect the backlog of testing around the holidays, the number of positive self-tests not registered, and burdened surveillance systems that miss cases around the word," said the WHO Director General.

Amid an ongoing resurgence across the world, the global coronavirus caseload has topped 297 million, while the deaths have surged to more than 5.46 million and vaccinations to over 9.27 billion, according to Johns Hopkins University.

In its latest update on Thursday morning, the University's Center for Systems Science and Engineering (CSSE) revealed that the current global caseload and the death toll stood at 297,504,250 and 5,464,532, respectively, while the total number of vaccine doses administered has increased to 9,279,347,173.

The US continues to be the worst-hit country with the world's highest number of cases and deaths at 57,649,131 and 832,061, according to the CSSE. The second worst hit country in terms of cases is India (35,018,358 infections and 482,551 deaths), followed by Brazil (22,328,252 infections and 619,654 deaths).

MORE International ARTICLES

Trump formally lets Canadian aluminum off hook

Trump formally lets Canadian aluminum off hook
The U.S. president formally signed a proclamation today exempting Canadian aluminum exports from punitive Section 232 tariffs.

Trump formally lets Canadian aluminum off hook

Prince Harry says ignorance no excuse for unconscious bias

Prince Harry says ignorance no excuse for unconscious bias
Harry talked about racial inequality and social justice in a video discussion with the Black Lives Matter activist Patrick Hutchinson as part of the GQ Heroes Conference, which is being broadcast this week.

Prince Harry says ignorance no excuse for unconscious bias

Halloween goes on at the White House with a few twists

Halloween goes on at the White House with a few twists
In years past, the president and first lady personally handed out candy to the costume-clad kids. This year, the treats were provided separately as participants walked along a path on the South Lawn.

Halloween goes on at the White House with a few twists

AstraZeneca resuming US testing of COVID-19 vaccine

AstraZeneca resuming US testing of COVID-19 vaccine
The AstraZenca vaccine, developed with Oxford University, is one of several coronavirus vaccine candidates in final-stage testing around the world.

AstraZeneca resuming US testing of COVID-19 vaccine

FDA approves first COVID-19 drug: antiviral remdesivir

FDA approves first COVID-19 drug: antiviral remdesivir
The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days — from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health.

FDA approves first COVID-19 drug: antiviral remdesivir

Here we go again: Trump, Biden reprise debate duel

Here we go again: Trump, Biden reprise debate duel
Instead, they're bracing for another show of vintage Trump, one in which he'll seek to be heard even in spite of his muted microphone.

Here we go again: Trump, Biden reprise debate duel